Your browser doesn't support javascript.
loading
Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia.
Ishrat, Tauheed; Soliman, Sahar; Eldahshan, Wael; Pillai, Bindu; Ergul, Adviye; Fagan, Susan C.
Afiliação
  • Ishrat T; Department of Anatomy and Neurobiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), 855 Monroe Ave, Rm 231-Wittenborg bldg., Memphis, TN, 38163, USA. tishrat@uthsc.edu.
  • Soliman S; Charlie Norwood VA Medical Center, and Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA, USA.
  • Eldahshan W; Charlie Norwood VA Medical Center, and Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA, USA.
  • Pillai B; Charlie Norwood VA Medical Center, and Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA, USA.
  • Ergul A; Charlie Norwood VA Medical Center, and Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA, USA.
  • Fagan SC; Department of Physiology, Augusta University, Augusta, GA, USA.
Neurochem Res ; 43(10): 1869-1878, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30088238

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Infarto da Artéria Cerebral Média / Fator B de Crescimento do Endotélio Vascular Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Infarto da Artéria Cerebral Média / Fator B de Crescimento do Endotélio Vascular Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos